These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23318987)

  • 1. What can be learned from a chaotic cancer model?
    Letellier C; Denis F; Aguirre LA
    J Theor Biol; 2013 Apr; 322():7-16. PubMed ID: 23318987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment and lymphocyte infiltration.
    Rahir G; Moser M
    Cancer Immunol Immunother; 2012 Jun; 61(6):751-9. PubMed ID: 22488275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do tumors actively escape from host immunosurveillance?
    Wilczyński JR; Duechler M
    Arch Immunol Ther Exp (Warsz); 2010 Dec; 58(6):435-48. PubMed ID: 20922572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and immunity in the tumor environment.
    Maletzki C; Emmrich J
    Dig Dis; 2010; 28(4-5):574-8. PubMed ID: 21088404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor infiltrating lymphocytes: indicators of tumor-related immune responses.
    Odunsi K; Old LJ
    Cancer Immun; 2007 Feb; 7():3. PubMed ID: 17311362
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer and immune response: old and new evidence for future challenges.
    de la Cruz-Merino L; Grande-Pulido E; Albero-Tamarit A; Codes-Manuel de Villena ME
    Oncologist; 2008 Dec; 13(12):1246-54. PubMed ID: 19056856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An outsider's perspective--ecotaxis revisited: an integrative review of cancer environment, iron and immune system cells.
    de Sousa M
    Integr Biol (Camb); 2011 Apr; 3(4):343-9. PubMed ID: 21180734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodic and chaotic dynamics in a map-based model of tumor-immune interaction.
    Moghtadaei M; Hashemi Golpayegani MR; Malekzadeh R
    J Theor Biol; 2013 Oct; 334():130-40. PubMed ID: 23770106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chaotic behavior of semigroups related to the process of gene amplification-deamplification with cell proliferation.
    Banasiak J; Lachowicz M; Moszyński M
    Math Biosci; 2007 Apr; 206(2):200-15. PubMed ID: 16199064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance.
    Sasada T; Suekane S
    Immunotherapy; 2011 Oct; 3(10):1235-51. PubMed ID: 21995574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory cell infiltration of tumors: Jekyll or Hyde.
    Talmadge JE; Donkor M; Scholar E
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):373-400. PubMed ID: 17717638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-linear model of cancer growth and metastasis: a limiting nutrient as a major determinant of tumor shape and diffusion.
    Pescarmona GP; Scalerandi M; Delsanto PP; Condat CA
    Med Hypotheses; 1999 Dec; 53(6):497-503. PubMed ID: 10687891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On optimal chemotherapy with a strongly targeted agent for a model of tumor-immune system interactions with generalized logistic growth.
    Ledzewicz U; Olumoye O; Schättler H
    Math Biosci Eng; 2013 Jun; 10(3):787-802. PubMed ID: 23906150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer.
    Badoual C; Hans S; Merillon N; Van Ryswick C; Ravel P; Benhamouda N; Levionnois E; Nizard M; Si-Mohamed A; Besnier N; Gey A; Rotem-Yehudar R; Pere H; Tran T; Guerin CL; Chauvat A; Dransart E; Alanio C; Albert S; Barry B; Sandoval F; Quintin-Colonna F; Bruneval P; Fridman WH; Lemoine FM; Oudard S; Johannes L; Olive D; Brasnu D; Tartour E
    Cancer Res; 2013 Jan; 73(1):128-38. PubMed ID: 23135914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor infiltrating regulatory T cells: tractable targets for immunotherapy.
    Khan AR; Dovedi SJ; Wilkinson RW; Pritchard DI
    Int Rev Immunol; 2010 Oct; 29(5):461-84. PubMed ID: 20839911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How regulatory CD25(+)CD4(+) T cells impinge on tumor immunobiology? On the existence of two alternative dynamical classes of tumors.
    Leon K; Garcia K; Carneiro J; Lage A
    J Theor Biol; 2007 Jul; 247(1):122-37. PubMed ID: 17412365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial avascular growth of tumor in a homogeneous environment.
    Viger L; Denis F; Draghi C; Ménard T; Letellier C
    J Theor Biol; 2017 Mar; 416():99-112. PubMed ID: 28017801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity.
    van Ravenswaay Claasen HH; Kluin PM; Fleuren GJ
    Lab Invest; 1992 Aug; 67(2):166-74. PubMed ID: 1501443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of lymphopoiesis as a function of the thymic microenvironment. Use of CD8+ cytotoxic T lymphocytes for cellular immunotherapy of human cancer.
    Bodey B
    In Vivo; 1994; 8(5):915-43. PubMed ID: 7727741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.